[1]高 亚,曹 晖,宾东华,等.芍药汤治疗湿热内蕴型溃疡性结肠炎疗效及对患者炎症因子和T淋巴细胞亚群的影响[J].陕西中医,2024,(10):1336-1339,1344.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.008]
　GAO Ya,CAO Hui,BIN Donghua,et al.Shaoyao decoction in the treatment of damp-heat intrinsic syndrome UC patients and its effect on inflammatory factors and T lymphocyte subsets[J].,2024,(10):1336-1339,1344.[doi:DOI:10.3969/j.issn.1000-7369.2024.10.008]
点击复制

芍药汤治疗湿热内蕴型溃疡性结肠炎疗效及对患者炎症因子和T淋巴细胞亚群的影响

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年10期
页码:
1336-1339,1344
栏目:
临床研究
出版日期:
2024-10-05

文章信息/Info

Title:
Shaoyao decoction in the treatment of damp-heat intrinsic syndrome UC patients and its effect on inflammatory factors and T lymphocyte subsets
作者:
高 亚1; 曹 晖1; 宾东华1; 曾婷婷1; 黄若茹2; 夏裔灵2
(1.湖南中医药大学第一附属医院,湖南 长沙 410125; 2.湖南中医药大学,湖南 长沙 410208)
Author(s):
GAO Ya; CAO Hui; BIN Donghua; ZENG Tingting; HUANG Ruoru; XIA Yiling
(The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine,Changsha 410125,China)
关键词:
溃疡性结肠炎;  湿热内蕴证;  芍药汤;  炎症因子;  T淋巴细胞亚群;  肿瘤坏死因子-α
Keywords:
Ulcerative colitis;  Damp heat intrinsic syndrome;  Shaoyao decoction;  Inflammatory factors;  T lymphocyte subsets;  Tumor necrosis factor-α
分类号:
R 574.62
DOI:
DOI:10.3969/j.issn.1000-7369.2024.10.008
文献标志码:
A
摘要:
目的:观察芍药汤治疗溃疡性结肠炎(UC)患者(湿热内蕴证)的临床疗效及对患者炎症因子和T淋巴细胞亚群的影响。方法:选择接受治疗的110例UC患者作为研究对象,掷硬币法分为两组,各55例。对照组采取美沙拉秦治疗,观察组在对照组基础上采取芍药汤治疗,两组均连续治疗3个月。治疗3个月时比较两组患者临床疗效; 比较两组治疗前、治疗3个月时临床症状、Mayo、Geboes指数评分、炎症因子、T淋巴细胞亚群(CD4+、CD8+、CD4+/CD8+)及肠道菌群水平; 统计并比较两组治疗期间不良反应发生情况。结果:治疗后,观察组总有效率高于对照组(P<0.05); 治疗后,两组主症、次症及总分低于治疗前,观察组低于对照组(P<0.05); 治疗后,两组Mayo活动指数、Geboes指数评分低于治疗前,观察组低于对照组(P<0.05); 治疗后,两组超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6)水平低于治疗前,观察组低于对照组(P<0.05); 治疗后,两组CD4+、CD4+/CD8+高于治疗前,CD8+低于治疗前,观察组CD4+、CD4+/CD8+高于对照组,CD8+低于对照组(P<0.05); 治疗后,两组双歧杆菌、乳酸杆菌高于治疗前,大肠杆菌低于治疗前,观察组大肠杆菌低于对照组(P<0.05); 观察组发生1例恶心,1例皮肤瘙痒,对照组未发生不良反应(P>0.05)。结论:芍药汤能够有效改善湿热内蕴证UC患者临床症状,促进肠黏膜愈合,降低机体炎症反应,提高免疫功能,恢复胃肠道菌群平衡,提升临床疗效。
Abstract:
Objective:To analyze the clinical efficacy of Shaoyao decoction in the treatment of ulcerative colitis(UC)patients(damp-heat intrinsic syndrome)and its effect on inflammatory factors and T lymphocyte subsets in patients.Methods:A total of 110 UC patients were selected as the research objects.Coin tossing method,they were divided into observation group(mesalazine)and control group(Shaoyao decoction),with 55 cases in each group.The two groups were treated continuously for 3 months.The clinical symptoms,Mayo,Geboes index scores,inflammatory factors [high-sensitivity C-reactive protein(hs-CRP),tumor necrosis factor-α(TNF-α),interleukin-6(IL-6)],T lymphocyte subsets(CD4+,CD8+,CD4+/CD8+)and intestinal flora levels were compared between the two groups before treatment and 3 months after treatment.The incidence of adverse reactions during treatment was counted and compared between the two groups.Results:After treatment,The clinical symptom scores of the observation group were lower than those of the control group(P<0.05).After treatment,the Mayo activity index and Geboes index scores of the observation group was lower than the control group(P<0.05).After treatment,the levels of hs-CRP,TNF-α and IL-6 in the observation group were lower than those in the control group(P<0.05).After treatment,CD4+ and CD4+/CD8+ in the observation group were higher than those in the control group,and CD8+ was lower than that in the control group(P<0.05).After treatment,Escherichia coli in the observation group was lower than that in the control group(P<0.05).One case of nausea and one case of skin itching occurred in the observation group,and no adverse reactions occurred in the control group(P>0.05).Conclusion:Shaoyao decoction can effectively improve the clinical symptoms of UC patients with damp-heat syndrome,promote the healing of intestinal mucosa,reduce the body's inflammatory response,improve immune function,restore the balance of gastrointestinal flora,improve clinical efficacy.

参考文献/References:

[1] 贺冰洁,刘志科,沈鹏,等.2011-2020年宁波市鄞州区炎症性肠病发病的流行病学研究[J].北京大学学报(医学版),2022,54(3):511-519.
[2] 尹平,郭朋璐,宋君宇.美沙拉嗪联合参苓白术散治疗溃疡性结肠炎的效果观察[J].河北医药,2021,43(24):3741-3744.
[3] 米拉木古丽?哈尔肯,刘欢,郭杰洁,等.初诊溃疡性结肠炎患者与复发相关的营养代谢危险因素的队列研究[J].中华临床营养杂志,2022,30(5):257-265.
[4] SUN Y X,WANG X,LIAO X,et al.An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis[J].BMC Complement Med Ther,2021,21(1):228.
[5] 赖曼,李娟,李瑶,等.芍药汤加减联合FOLFOX6方案,常规治疗对湿热蕴结型结直肠癌术后辅助化疗患者的临床疗效[J].中成药,2022.44(9):2834-2838.
[6] SIDDIQUE I,ALAZMI W,ALALI J,et al.Demography and clinical course of ulcerative colitis in Arabs:A study based on the montreal classification[J].Scand J Gastroenterol,2014,49(12):1432-1440.
[7] JAIN S,KEDIA S,BOPANNA S,et al.Are truelove and witts criteria for diagnosing acute severe colitis relevant for the Indian population?A prospective study[J].Intest Res,2018,16(1):69-74.
[8] 中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年,北京)[J].中华消化杂志,2018,38(5):292-311.
[9] 国家食品药品监督管理总局.中药新药临床研究指导原则:试行[J].北京:中国医药科技出版社,2002:129-130.
[10] DI RUSCIO M,VARIOLA A,VERNIA F,et al.Role of ulcerative colitis endoscopic index of severity(UCEIS)versus mayo endoscopic subscore(MES)in predicting patients' response to biological therapy and the need for colectomy[J].Digestion,2021,102(4):534-545.
[11] MAGRO F,ALVES C,LOPES J,et al.Histologic features of colon biopsies(Geboes score)associated with progression of ulcerative colitis for the first 36 months after biopsy[J].Clin Gastroenterol Hepatol,2021,19(12):2567-2576.
[12] 安敏,高振军.美沙拉秦长期治疗对溃疡性结肠炎患者结肠黏膜癌相关基因表达的影响[J].陕西医学杂志,2021,50(4):485-488.
[13] SMETS G,GROSBER M,GUTERMUTH J,et al.Mesalazine-induced eosinophilic glossitis and hypereosinophilia in a patient with ulcerative colitis:A case report and review of literature[J].J Eur Acad Dermatol Venereol,2021,35(7):462-464.
[14] DEISSLER H,KRAMMER H,GILLESSEN A.pH-dependent vs.constant release of mesalazine in the treatment of ulcerative colitis:Do drug delivery concepts determine therapeutic efficacy?(Review)[J].Biomed Rep,2021,15(5):96.
[15] ZHENG S,XUE T,WANG B,et al.Chinese medicine in the treatment of ulcerative colitis:The mechanisms of signaling pathway regulations[J].Am J Chin Med,2022,50(7):1781-1798.
[16] 首汉蓉,唐建,黄泽林,等.黄芩汤加减联合补脾益肠丸对溃疡性结肠炎患者Toll样受体4/髓样分化因子88信号通路的影响[J].陕西中医,2020,41(6):750-753.
[17] 白鹏飞,张艳君,李敏.荆芥连翘汤加减从肺论治溃疡性结肠炎疗效及对患者肠黏膜屏障功能、免疫调节、氧化应激指标的影响[J].陕西中医,2020,41(7):897-900.
[18] 王巍,索天娇,张强,等.黄芩不同炮制品的质量及抗溃疡性结肠炎作用比较研究[J].现代中药研究与实践,2021,35(3):43-46.
[19] GAN L,YAN Y J,DING Q,et al.Research on quality difference of standard decoction of raw and fried paeoniae radix alba based on fingerprint and multicomponent determination[J].Chin Pharm J,2021,46(6):1410-1416.
[20] LI D,CUI L,GAO Y,et al.Fecal microbiota transplantation improves intestinal inflammation in mice with ulcerative colitis by modulating intestinal flora composition and down-regulating NF-κB signaling pathway[J].Microb Pathog,2022,173(11):105803.
[21] DAI Y,LU Q,LI P,et al.Xianglian pill attenuates ulcerative colitis through TLR4/MyD88/NF-kappa B signaling pathway[J].J Ethnopharmacol,2023,10(300):115690.
[22] XIONG T,ZHENG X,ZHANG K,et al.Ganluyin ameliorates DSS-induced ulcerative colitis by inhibiting the enteric-origin LPS/TLR4/NF-kappaB pathway[J].J Ethnopharmacol,2022,10(89):115001.
[23] 郑烈,段盛蕾,戴彦成.芍药汤介导不同信号通路治疗溃疡性结肠炎作用机制的研究进展[J].中华中医药学刊,2023,41(5):24-28.
[24] JAN R,KHAN M,ASAF S,et al.Bioactivity and therapeutic potential of kaempferol and quercetin:New insights for plant and human health[J].Plants(Basel),2022,11(19):2623.
[25] CUI L,GUAN X,DING W,et al.Scutellaria baicalensis georgi polysaccharide ameliorates DSS-induced ulcerative colitis by improving intestinal barrier function and modulating gut microbiota[J].Int J Biol Macromol,2021,166(16):1035-1045.

相似文献/References:

[1]陈 岚,贾 波△,邓怀涵,等.基于“逆流挽舟”法探索人参败毒散对溃疡性结肠炎模型大鼠〖JZ〗胃肠功能的影响及作用机制*[J].陕西中医,2019,(3):283.
[2]陈立冬,刘智慧,于 蕊.康复新液灌肠联合美沙拉嗪治疗溃疡性结肠炎疗效研究*[J].陕西中医,2019,(9):1187.
[3]乔峰,强文娟,高东,等.葛根芩连汤配合针刺治疗溃疡性结肠炎活动期大肠湿热证临床研究*[J].陕西中医,2019,(11):1516.
　QIAO Feng,QIANG Wenjuan,GAO Dong,et al.Gegen Qinlian decoction combined with acupuncture for ulcerative colitis with large intestine dampheat syndrome at active stage[J].,2019,(10):1516.
[4]史英,张铁△,祝斌野,等.溃结2号方治疗脾虚湿盛型溃疡性结肠炎临床研究*[J].陕西中医,2019,(11):1520.
　SHI Ying,ZHANG Tie,ZHU Binye,et al.Clinical observation on Kuijie No.2 recipe in treating ulcerative colitis of spleen deficiency and dampness[J].,2019,(10):1520.
[5]赵克学,徐 辰,戴高中,等.愈疡膏外敷联合西药治疗复发型活动期溃疡性结肠炎临床研究*[J].陕西中医,2020,(5):600.[doi:DOI:10.3969/j.issn.10007369.2020.05.013]
　ZHAO Kexue,XU Chen,DAI Gaozhong,et al.Observation on the efficacy of Yuyang plaster combined with western medicine in the treatment of recurrent active ulcerative colitis[J].,2020,(10):600.[doi:DOI:10.3969/j.issn.10007369.2020.05.013]
[6]白鹏飞,张艳君,李 敏.荆芥连翘汤加减从肺论治溃疡性结肠炎疗效及对患者肠黏膜屏障功能、免疫调节、氧化应激指标的影响*[J].陕西中医,2020,(7):897.[doi:DOI:10.3969/j.issn.10007369.2020.07.017]
　BAI Pengfei,ZHANG Yanjun,LI Min..Effect of treating ulcerative colitis with nepeta forsythia decoction and its influence on intestinal barrier function,immune regulation and oxidative stress[J].,2020,(10):897.[doi:DOI:10.3969/j.issn.10007369.2020.07.017]
[7]郭 琳,王雅婷,考延磊,等.闫雪洁运用寒热并用法治疗溃疡性结肠炎经验*[J].陕西中医,2020,(8):1148.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.036]
　GUO Lin,WANG Yating,KAO Yanlei,et al.Clinical experience of YAN Xuejie in treating ulcerative colitis with the theory of combination of cold and heat[J].,2020,(10):1148.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.036]
[8]梁 想,王梅青△.参苓白术散联合美沙拉嗪治疗溃疡性结肠炎疗效研究[J].陕西中医,2020,(9):1251.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.021]
[9]袁子云,杜晓泉△.杜晓泉运用健脾调肠汤治疗溃疡性结肠炎脾虚湿热证经验总结*[J].陕西中医,2020,(12):1800.[doi:DOI:10.3969/j.issn.1000-7369.2020.12.032]
[10]张 波,惠永峰,李海玲,等.益脾祛湿理肠汤治疗溃疡性结肠炎疗效及对患者肠黏膜屏障功能的影响[J].陕西中医,2021,(8):1024.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.009]
　ZHANG Bo,HUI Yongfeng,LI Hailing,et al.Yipi Qushi Lichang decoction on ulcerative colitis and its influence on intestinal mucosal barrier function[J].,2021,(10):1024.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.009]
[11]邹林焘,邹正华,杜学芳.清肠解毒汤治疗溃疡性结肠炎湿热内蕴证临床研究[J].陕西中医,2021,(5):597.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.013]
　ZOU Lintao,ZOU Zhenghua,DU Xuefang.Qingchang Jiedu decoction in the treatment of ulcerative colitis with internal accumulation of damp-heat[J].,2021,(10):597.[doi:DOI:10.3969/j.issn.1000-7369.2020.05.013]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81603634); 湖南省中医药科研计划项目(2021022)
更新日期/Last Update: 2024-10-08